Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.

Saved in:
Bibliographic Details
Title: Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.
Authors: Viti R; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy., Marcellusi A; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy. andrea.marcellusi@uniroma2.it.; Institute for Leadership and Management in Health, Kingston University London, London, UK. andrea.marcellusi@uniroma2.it., Capone A; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy., Matucci A; Immunoallergology Unit, AOU Careggi, University of Florence, Florence, Italy., Vultaggio A; Immunoallergology Unit, AOU Careggi, University of Florence, Florence, Italy., Pignata C; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy., Spadaro G; Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research, University of Naples Federico II, Naples, Italy., Vacca A; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy., Marasco C; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy., Agostini C; Department of Medicine (DIMED), Internal Medicine 1, Treviso Ca' Foncello Hospital, University of Padua, Padua, Italy., Mennini FS; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy.; Institute for Leadership and Management in Health, Kingston University London, London, UK.
Source: Clinical drug investigation [Clin Drug Investig] 2018 Oct; Vol. 38 (10), pp. 955-965.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30191508
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Viti+R%22">Viti R</searchLink>; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Marcellusi+A%22">Marcellusi A</searchLink>; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy. andrea.marcellusi@uniroma2.it.; Institute for Leadership and Management in Health, Kingston University London, London, UK. andrea.marcellusi@uniroma2.it.<br /><searchLink fieldCode="AU" term="%22Capone+A%22">Capone A</searchLink>; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Matucci+A%22">Matucci A</searchLink>; Immunoallergology Unit, AOU Careggi, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Vultaggio+A%22">Vultaggio A</searchLink>; Immunoallergology Unit, AOU Careggi, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Pignata+C%22">Pignata C</searchLink>; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Spadaro+G%22">Spadaro G</searchLink>; Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research, University of Naples Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Vacca+A%22">Vacca A</searchLink>; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Marasco+C%22">Marasco C</searchLink>; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Agostini+C%22">Agostini C</searchLink>; Department of Medicine (DIMED), Internal Medicine 1, Treviso Ca' Foncello Hospital, University of Padua, Padua, Italy.<br /><searchLink fieldCode="AU" term="%22Mennini+FS%22">Mennini FS</searchLink>; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy.; Institute for Leadership and Management in Health, Kingston University London, London, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2018 Oct; Vol. 38 (10), pp. 955-965.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30191508
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40261-018-0688-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 955
    Titles:
      – TitleFull: Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Viti R
      – PersonEntity:
          Name:
            NameFull: Marcellusi A
      – PersonEntity:
          Name:
            NameFull: Capone A
      – PersonEntity:
          Name:
            NameFull: Matucci A
      – PersonEntity:
          Name:
            NameFull: Vultaggio A
      – PersonEntity:
          Name:
            NameFull: Pignata C
      – PersonEntity:
          Name:
            NameFull: Spadaro G
      – PersonEntity:
          Name:
            NameFull: Vacca A
      – PersonEntity:
          Name:
            NameFull: Marasco C
      – PersonEntity:
          Name:
            NameFull: Agostini C
      – PersonEntity:
          Name:
            NameFull: Mennini FS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2018 Oct
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1918
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Clinical drug investigation
              Type: main
ResultId 1